Combined immunotherapeutic effect of Leishmania-derived recombinant aldolase and Ambisome against experimental visceral leishmaniasis
Background: Available therapeutics for visceral leishmaniasis (VL), a deadly parasitic infection, are usually associated with inadequate efficacy and adverse aftereffects. Further, the primary site of Leishmania parasite are host macrophages resulting in compromised immunity; ensuing marked T-cell i...
Main Authors: | Keerti, Narendra Kumar Yadav, Sumit Joshi, Sneha Ratnapriya, Amogh Anant Sahasrabuddhe, Anuradha Dube |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Journal of Microbiology, Immunology and Infection |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1684118222000949 |
Similar Items
-
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
by: David S. Lawrence, et al.
Published: (2018-11-01) -
Leishmania Resistance to Miltefosine Associated with Genetic Marker
by: Sandrine Cojean, et al.
Published: (2012-04-01) -
Subcellular localization studies of LdBPK_070020, a conserved protein of Leishmania donovani
by: Ruchika Bhardwaj, et al.
Published: (2016-01-01) -
Multifunctional Fructose 1,6-Bisphosphate Aldolase as a Therapeutic Target
by: David B. Pirovich, et al.
Published: (2021-08-01) -
Fructose biphosphate aldolase: A new cassava allergen
by: Anne K.R.M. Ventura, Ph.D, et al.
Published: (2023-12-01)